Recent Patents on Anti-Cancer Drug Discovery

Targeting Hormonal Signaling Pathways in Castration Resistant Prostate Cancer
pp. 267-285(19)
Authors: Manea, Marilena; Montagnani Marelli, Marina; M. Moretti, Roberta; Maggi, Roberto; Marzagalli, Monica; Limonta, Patrizia

MicroRNA Therapeutics: The Emerging Anticancer Strategies
pp. 286-296(11)
Authors: K. Jain, Chakresh; Gupta, Aman; Dogra, Nidhi; S. Kumar, Vipul; Wadhwa, Gulshan; K. Sharma, Sanjeev

Combination of Phytochemicals as Adjuvants for Cancer Therapy
pp. 297-302(6)
Authors: W.S. Ho, John; W.M. Cheung, Matt

Anticancer Hybrids- A Patent Survey
pp. 303-339(37)
Authors: Nepali, Kunal; Sharma, Sahil; Kumar, Dinesh; Budhiraja, Abhishek; L. Dhar, Kanaya

Could Resveratrol be a Useful Drug for the Treatment of Malignant Hemopathies?
pp. 340-353(14)
Author: G. Mihaila, Romeo

Novel Patents and Cancer Therapies for Transforming Growth Factor- Beta and Urokinase Type Plasminogen Activator: Potential Use of Their Interplay in Tumorigenesis
pp. 354-371(18)
Authors: Krstic, Jelena; Maslovaric, Irina; F. Santibanez, Juan

Lung Cancer Chemotherapy, New Treatment and Related Patents
pp. 372-381(10)
Authors: Cheepsattayakorn, Attapon; Cheepsattayakorn, Ruangrong

Next Generation Tyrosine Kinase Inhibitor (TKI): Afatinib
pp. 382-393(12)
Authors: Kumar, Suresh; Agrawal, Ritesh

Patent Selections:
pp. 394-397(4)

Acknowledgement to Contributors
pp. 398-398(1)

Acknowledgement to Reviewers
pp. 399-400(2)